Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
603858 Shandong Buchang Pharmaceuticals
- 15.89
- +0.06+0.38%
Not Open May 15 15:00 CST
17.58BMarket Cap-48.74P/E (TTM)
16.00High15.75Low42.22KlotVolume15.82Open15.83Pre Close67.14MTurnover0.38%Turnover RatioLossP/E (Static)1.11BShares19.7052wk High1.68P/B17.58BFloat Cap13.8352wk Low17.41Limit Up1.11BShs Float86.04Historical High14.25Limit Down1.58%Amplitude13.36Historical Low0.13Dividend TTM15.90Avg Price19.53KlotAsk0.79%Div YieldTTM100Lot Size21.50KlotBid
Shandong Buchang Pharmaceuticals Key Stats
Shandong Buchang Pharmaceuticals Q1 2025 Earnings Date
Currency：CNYApr 26, 2025
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | -- | 2.78B | -- |
+5.47% | |||
| EPS | -- | 0.29 | -- |
+180.10% |
Analyst Rating
No Data
Shandong Buchang Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
No Data
Shandong Buchang Pharmaceuticals Earnings Reports
Read more
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting